GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
AVEO Pharmaceuticals, Inc. (AVEO) [hlAlert]

AVEO Pharmaceuticals, Inc. (AVEO) is a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics. Its product candidates are directed against mechanisms known to be involved in cancer. The Company?s product, Tivozanib, is a potent and selective oral inhibitor of the vascular endothelial growth factor (VEGF),
receptors 1, 2 and 3. It completed a 272-patient phase two clinical trial of tivozanib in patients with advanced renal cell cancer (RCC). In December 2009, the Company initiated a phase three clinical trial of tivozanib in patients with advanced RCC, in which it focuses to enroll 500 patients, referred to as the TIVO-1 study. The TIVO-1 study is a randomized, controlled clinical trial of tivozanib compared to Nexavar (sorafenib) in advanced RCC patients who have not received any prior VEGF-targeted therapy. Nexavar is an oral VEGF receptor inhibitor approved for the treatment of RCC.
.
( Total: 9 Current Stock Recommendations )
AVEO Pharmaceuticals, Inc.   (9)
Sell Hold 78% Buy
Related companies
ATHERSYS INC   (7)
Buy 100%
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
5/3/2013  
Hold
  
5/13/2011  
Hold
  
5/3/2013  
Hold
  
8/3/2012  
Hold
  
10/8/2012  
Hold
  
3/9/2015  
Hold
  
4/21/2010  
Buy
  
11/14/2012  
Sell
  
4/2/2013  
Hold
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy